Stacking BPC-157 and TB-500: Tracking the Combination
The BPC-157 + TB-500 stack is the most common combination in the recovery space. The rationale is mechanism-complementary: BPC-157 acts on growth factors and angiogenesis, TB-500 on actin sequestration and cell migration. Used together, the claim is faster healing of soft-tissue injuries than either alone.
Typical stack protocol
- BPC-157: 250–500 mcg/day subcutaneous, often near the injury site
- TB-500: loading at 5 mg/week (split into 2 doses) for 4–6 weeks, maintenance 2 mg/week
- Stack length: 4–8 weeks, then 4-week off-cycle
Tracking complications when running both
Two compounds means two reconstitution profiles, two dose schedules, two site-rotation histories that need to interlock (you don't want both injections in the same site on the same day). Peptra handles stacks as first-class. Each compound has its own log, its own site map, its own cycle window.
What to track beyond doses
For recovery stacks: subjective recovery rating (1–10), targeted symptom scores (pain at injury site, range of motion if applicable), training load if you're an athlete. Side effects: most users on this stack report nothing, but log lethargy, lightheadedness, or injection-site reactions if they happen.